Donald Trump’s administration is preparing to suggest that using paracetamol while pregnant could increase the risk of autism. This announcement has sparked concerns among experts in the UK. According to reports, US health secretary Robert F Kennedy Jr is expected to claim that Tylenol, also known as paracetamol in the UK, might be linked to autism.

A federal report is anticipated to recommend a specific form of folate as a treatment for autism. Trump stated, “I think we found an answer to autism.” However, the UK’s NHS website states that paracetamol is safe for pregnant women and is a common pain relief choice during pregnancy.

Dr. Monique Botha, an associate professor at Durham University, emphasized that numerous studies, including a significant Swedish study involving 2.4 million births, have found no connection between paracetamol exposure during pregnancy and autism. She stressed that there is insufficient evidence to support any causal link and that fearmongering about paracetamol could prevent women from accessing necessary care during pregnancy.

Dimitrios Siassakos, a professor in obstetrics, highlighted that autism is influenced by various factors, such as genetic predisposition and birth complications. Research indicates that any perceived risk related to paracetamol use during pregnancy diminishes when considering other critical factors. Professor Claire Anderson from the Royal Pharmaceutical Society affirmed the safety of paracetamol, mentioning a large 2024 study that found no association between paracetamol use in pregnancy and autism risk in children.

The discussion on paracetamol and autism underscores the need for balanced information and cautious consideration of all contributing factors to ensure the well-being of pregnant women and their children.